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Aeruginosins represent a group of peptide me-
tabolites isolated from various cyanobacterial
genera and from marine sponges that potently
inhibit different types of serine proteases. Mem-
bers of this family are characterized by the pres-
ence of a 2-carboxy-6-hydroxyoctahydroindole
(Choi) moiety. We have identified and fully se-
quenced a NRPS gene cluster in the genome
of the cyanobacterium Planktothrix agardhii
CYA126/8. Insertional mutagenesis of a NRPS
component led to the discovery and structural
elucidation of two glycopeptides that were des-
ignated aeruginoside 126A and aeruginoside
126B. One variant of the aglycone contains a
1-amino-2-(N-amidino-D3-pyrrolinyl)ethyl moi-
ety at the C terminus, the other bears an agma-
tine residue. In silico analyses of the aerugino-
side biosynthetic genes aerA-aerI as well as
additional mutagenesis and feeding studies al-
lowed the prediction of enzymatic steps leading
to the formation of aeruginosides and the un-
usual Choi moiety.
INTRODUCTION
Cyanobacteria provide a broad range of biologically active
compounds, many of which are highly intriguing from
a structural point of view [1]. In particular, cyanobacterial
peptides are often composed of highly unusual amino
acids. A good example is the group of aeruginosins, which
are characterized by an N-terminal derivative of an aryl
lactic acid, a 2-carboxy-6-hydroxyoctahydroindole (Choi)
moiety, and an arginine derivative at the C-terminal posi-Chemistry & Biology 14, 5tion [2]. Different variants of aeruginosin have been iso-
lated from the planktonic cyanobacterial genera Micro-
cystis, Oscillatoria (Planktothrix), Nodularia, and from
marine sponges [2–11]. Aeruginosins are potent inhibitors
of serine proteases with different specificities for trypsin
and thrombin, respectively. Two specific aeruginosins
have also been crystallized bound to their protease targets
trypsin and thrombin, respectively, in order to assess the
structure-activity relationships [12, 13].
The majority of cyanobacterial peptides is synthesized
by modular biosynthetic assembly lines, so-called nonri-
bosomal peptide synthetases (NRPS) [1, 14]. A NRPS
module is minimally composed of an amino acid-activat-
ing adenylation (A) domain, a peptidyl carrier protein (PCP)
domain, and a condensation (C) domain [15]. In the last
decade, a number of such NRPS systems have been de-
scribed from cyanobacteria. Biosynthesis genes for the
production of the widespread cyanobacterial hepatotoxin
microcystin were detected and characterized inMicrocys-
tis, Planktothrix, and Anabaena, three distant cyanobacte-
rial genera that form blooms in freshwater habitats [16–
19]. The microcystin pathway exemplifies the prevalence
of mixed NRPS/polyketide synthase (PKS) pathways,
which is a major theme of cyanobacterial biosyntheses.
This biosynthetic principle is also seen in several path-
ways that have been reported from the marine cyanobac-
terium Lyngbya majuscula, namely the barbamide, jamai-
camide, and curacin pathways [20–22]. Natural product
biosyntheses from cyanobacteria have further attracted
attention because of their unique tailoring enzymes, in-
cluding diverse forms of halogenases and aromatic prenyl
transferases [20, 23, 24]. These fascinating properties of
cyanobacterial NRPS/PKS pathways make them particu-
larly interesting for pathway engineering approaches. It
was therefore tempting to investigate the natural biosyn-
thetic machinery of the structurally unique aeruginosin
and its core moiety Choi.65–576, May 2007 ª2007 Elsevier Ltd All rights reserved 565
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Aeruginoside Biosynthesis in CyanobacteriaFigure 1. Inactivation of NRPS Presum-
ably Involved in Aeruginosin Biosynthe-
sis by Homologous Recombination and
HPLC Analysis of Wild-Type and Mutant
(A) Schematic representation of DNRPS-D-Leu
knockout plasmids for the insertional muta-
genesis of P. agardhii CYA126/8. The chloram-
phenicol resistance gene cassette (Cmr) is
highlighted in black.
(B) PCR amplification with the DNA from wild-
type (WT) and DNRPS-D-Leu mutant (MT) with
primers amplifying the region flanking the in-
sertion site.
(C) HPLC-DAD profile of extract from Plankto-
thrix agardhii CYA126/8 wild-type.
(D) HPLC-DAD profile of extract from DNRPS-
D-Leu mutant. The peaks at min 9.07 (1) and
10.56 (2) represent putative aeruginosins, the
peaks at min 26.6 (3) and 33.8 (4) [D-Asp]-
microcystin-RR and [D-Asp]-microcystin-LR,
respectively.Here, we report the cloning, sequencing, and mutational
analysis of a gene cluster encoding aeruginosin biosyn-
thesis in Planktothrix agardhii CYA126/8 as well as the
full structural elucidation of two previously unreported
glycosylated aeruginosin variants, aeruginosides 126A
and 126B.
RESULTS AND DISCUSSION
Identification of the Aeruginoside Gene
Cluster via Gene Disruption
A candidate gene cluster for the biosynthesis of the aeru-
ginosides was identified in the course of a search for NRPS
genes by a degenerate PCR approach in Planktothrix
CYA126/8 [16]. Subsequently, individual PCR fragments
were cloned and sequenced and used to screen a phage-
mide library of the strain. As a result, a gene fragment was
identified encoding a NRPS module comprising an A do-
main, a PCP domain, and an epimerization (E) domain
(Figure 1A). Analysis of the specificity conferring residues
of the amino acid binding pocket [25] and comparison with
characterized sequences in the database revealed a puta-
tive specificity of the A domain for leucine (Figure 1A and
Table S1 available with this article online). Furthermore,
the presence of an epimerization domain suggested that
the module could be responsible for the incorporation of
a D-leucine moiety into a cyanopeptide structure. Leucine
is common in several cyanobacterial peptide families;
however, the D stereoisomer is characteristic for some
aeruginosin variants that have been described from
Microcystis [6]. Although Planktothrix CYA126 was known
to produce a number of different peptides including puta-
tive aeruginosin variants [16], no detailed structural in-
formation on aeruginosins from CYA126 was available.
In order to confirm the proposed involvement of the
gene fragment in aeruginosin biosynthesis, an insertional
mutagenesis of the gene in Planktothrix CYA126 was initi-
ated by using a homologous recombination strategy. For
this purpose a chloramphenicol resistance cassette was566 Chemistry & Biology 14, 565–576, May 2007 ª2007 Elsevieinserted into the NRPS gene fragment, and the resulting
construct was introduced into the Planktothrix cells by
electroporation. Following selection in liquid medium,
mutant clones were obtained. Subsequent PCR using
primers distal to the insertion region revealed the success-
ful insertion of the resistance cassette and the homozy-
gosity of the mutants (Figure 1B).
Identification and Structural Elucidation
of Aeruginosides 126A and 126B
The composition of the peptide fraction of wild-type cells
and of mutant cells cultured in the presence of chloram-
phenicol was compared by HPLC-DAD analysis. This anal-
ysis revealed that in the extract from the mutant, three
peaks were missing (Figures 1C and 1D and data not
shown). MALDI-TOFMS analysis for two of these indicated
molecular masses of 714 and 690, respectively (data not
shown). These masses did not match those of any known
aeruginosin-type molecules, which suggested that these
compounds might be new. Thus, the peaks missing in
the mutant were collected from large-scale laboratory cul-
tures of the wild-type. Two metabolites, aeruginoside 126A
(1) and aeruginoside 126B (2), were obtained in sufficient
quantity, 0.8 mg and 0.4 mg, respectively, to allow for
a full spectroscopic characterization by NMR.
Positive ion HRESI-TOFMS analysis of 1 yielded a pseu-
domolecular ion (M+H)+ at m/z 715.4056, suggesting
a molecular formula of C36H55N6O9 (calc. 715.4031, D =
2.5 mmu). Inspection of the 1H and 13C NMR spectra
recorded in DMSO-d6 indicated the presence of two con-
formers in the ratio of 3:1. Only the data for the major con-
former are displayed in Table 1 and will be discussed in the
following. The 13C NMR spectrum showed 34 signals two
of which were assigned to methyl groups on the basis of
the analysis of gHSQC data, 11 to methylenes, 15 to me-
thines, and 6 to quaternary carbon atoms. This suggested
that the molecule contained a symmetrical substructure,
which was readily assigned to a phenyl group on the basis
of the 1H NMR spectrum. This aromatic ring accountedr Ltd All rights reserved
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NMR data, five of the remaining double-bond equivalents
were identified in the form of three carbonyl resonances,
a guanidine carbon atom, plus one C-C double bond.
Thus, 1 had to contain four additional rings (Figure S1).
The identification of individual residues was accom-
plished by means of 1D TOCSY spectra. In this fashion,
a leucine residue and a b-substituted lactic acid were
readily identified. The large geminal coupling constant
for the protons on C-3 of the latter suggested the presence
of a p-system in the b-position. Eventually, this residue
was identified as a phenyl lactic acid (Plac) on the basis
of gHMBC data and chemical shift considerations. Thus,
the assignment of the latter as an a-hydroxy acid rather
than an amino acid is based on the chemical shift for
C-2 (72.02 ppm) and H-2 (4.11 ppm). Further inspection
of the 13C NMR spectrum of 1 provided evidence for a
2-carboxy-6a-hydroxy-octahydroindole (Choi) subunit
with excellent agreement of the chemical shifts observed
for 1 and those reported in the literature. The only signifi-
cant chemical-shift difference noted was for the hydroxy-
methine carbon atom of 1 at d = 70.05 ppm, which was
shifted downfield (Dd z 6 ppm) in comparison to Choi
residues in other aeruginosin-type molecules (d = 63.8 to
64.1 ppm) [4, 6, 8]. Since the correct assignment of the
relative stereochemistry of the Choi residue has proven
problematic in the past, we paid particular attention to
this aspect. The cis stereochemistry of the ring junction
follows from the coupling constant 3J = 6.2 Hz observed
for H-7a. Confirmation of this stereochemistry by NOE
was not possible because of the overlap of the reso-
nances for H-7eq. and H-3a. All expected NOE’s were
observed (see Figure S2). Finally, the arginine mimetic
characteristic of the aeruginosin class of compounds
was identified as a 1-amino-2-(N-amidino-D3-pyrrolinyl)-
ethyl (Aeap) residue on the basis of gCOSY and gHMBC
data using the NH and the olefinic methine proton reso-
nances as starting points. This assignment was corrobo-
rated through chemical-shift comparison with literature
values [26, 27], which were in excellent agreement.
The subunits of 1 identified thus far account for all but
five carbon atoms, five oxygen atoms, and ten protons.
This elemental composition of the remainder suggested
the presence of a carbohydrate moiety in 1, and a proton
resonance at 4.81 ppm was tentatively assigned to the
anomeric proton of the putative sugar. In the HSQC spec-
trum, the signal for this proton correlates to a resonance at
96.5 ppm, a typical value observed for acetal carbon
atoms. Further analysis of gHMBC and gHSQC data led
to the identification of three additional hydroxymethine
and one hydroxymethylene carbon atom. The relative ste-
reochemistry of the sugar was established on the basis of
1D TOCSY data. The large 3J coupling constants (3J2,3 =
9.4 Hz; 3J3,4 = 8.8 Hz;
3J4,5ax = 10.6 Hz) observed for the
hydroxymethine protons on C-2, C-3, and C-4 of the sugar
suggested an all-axial arrangement of these protons in a
six-membered ring. Thus, the sugar residue in 1was iden-
tified as a xylopyranoside. The small coupling constant
between the anomeric proton and H-2 (3J = 3.4 Hz) wasChemistry & Biology 14, 5indicative of H-1 being equatorial and hence of the presence
of an a-glycosidic linkage. The observation of a gHMBC
correlation from H-1 of the sugar to C-6 (d = 70.05 ppm)
of the Choi residue indicates the site of attachment of
the sugar to the aglycone. This connectivity also explains
the downfield shift of the signal for this carbon atom, as
noted earlier, relative to that found in Choi units bearing
a free hydroxyl.
The sequence of the amino acids in the peptide was de-
termined by means of gHMBC correlations from the ex-
changeable NH proton of the leucine unit to C-1 of Plac
and from the NH-1 resonance of Aeap to the carboxyl res-
onance of Choi. No HMBC correlations were observed in
support of the bond between C-1 of leucine and the nitro-
gen atom of Choi. However, unambiguous evidence for
a connection between these units is furnished by very
strong NOE correlations between the aminomethine pro-
ton of leucine (4.50 ppm) and H-7a as well as H-7eq. of
the Choi unit.
Positive ion HRESI-TOFMS analysis of 2 yielded a pseu-
domolecular ion (M+H)+ at 691.4051, suggesting a molec-
ular formula of C34H54N6O9 (D = 2.0 mmu). As in the case
of 1, analysis of the NMR spectra of 2 revealed the pres-
ence of two conformers. Chemical-shift comparison of
the NMR spectra of 1 and 2 revealed excellent agreement
(Dd (13C)% 0.1ppm, Dd (1H)% 0.05ppm) for all but the ar-
ginine mimetic portion of the peptides. Analysis of gHMBC
and 1D TOCSY data then established that 2 was bearing
an agmatine rather than an Aeap moiety. Thus, the struc-
ture of 2 closely resembles the recently revised structure
of aeruginosin 205 [28]. The absolute stereochemistry of
the phenyl lactic acid and the leucine moiety of 1 was de-
termined after acid hydrolysis by chromatography on chi-
ral stationary phase and comparison of retention times to
those of authentic standards. The retention times of Plac
from 1matched that of D-Plac and that of leucine matched
the retention time of the D-leucine standard. The absolute
configuration of the xylose residue could not be estab-
lished (Table 1 and Figure 2). Aeruginoside 126A weakly
inhibited porcine pancreas trypsin and bovine plasma
thrombin with IC50 values of 67 and 30 mg/ml, respectively,
compared to aeruginosin 98-A [5] as a positive control
(0.07 and 2.5 mg/ml). Aeruginoside 126A did not inhibit
human plasma plasmin at a concentration of 100 mg/ml,
compared to aeruginosin 98-A [5] as a positive control
with IC50 value of 2.7 mg/ml.
Analysis of the Organization of the Aeruginoside
Gene Cluster and Flanking Regions
In order to obtain sequence information about the entire
gene cluster encoding aeruginosin biosynthesis, the orig-
inal fragment of the aeruginoside gene cluster was used as
a probe to screen a genomic phagemid library of Plankto-
thrix CYA126/8. Subsequently 35 kb were sequenced
from overlapping phagemide clones spanning the aerugi-
noside biosynthesis gene cluster and flanking regions.
Sequence analysis of the aeruginosin (aer) region revealed
the presence of 19 ORFs, nine of which could be assigned
to aeruginoside biosynthesis and therefore designated65–576, May 2007 ª2007 Elsevier Ltd All rights reserved 567
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Aeruginoside Biosynthesis in CyanobacteriaTable 1. NMR Spectral Data for Aeruginoside A (1) in DMSO-d6
Unit C/H No. dH (J in Hz) dC HMBC
Plac 1 173.2 Plac H-2, H-3, Leu NH
2 4.11, dd (8.8, 3.9) 72.02 Plac H-3a, H-3b
3a 2.95, dd (13.7, 3.9) 40.4 Plac H-2, H-5/9
3b 2.65, dd (13.7, 8.8)
4 138.4 Plac H-2, H-3a, H-3b, H-6/8
5/9 7.21, m 129.3 Plac H-3a, H-3b, H-7, H-9/5
6/8 7.24, m 127.9 Plac H-8/6
7 7.16, m 125.9 Plac H-5/9
Leu 1 169.9 Leu H-2
2 4.50, ddd (9.0, 7.9, 4.8) 48.6 Leu H-3a
3a 1.46, m 41.0 Leu H-4, H-5, H-50
3b 1.34, m
4 1.48, m 24.1 Leu H-3a, H-5, H-50
5 0.86, d (6.5) 21.8 Leu H-3a, H-3b, H-50
50 0.84, d (6.4) 23.3 Leu H-3b, H-5
NH 7.76, d (7.9)
Choi 1 171.4 Choi H-2, Aeap NH, H-1
2 4.18, dd (9.0, 7.8) 59.8 Choi H-7a
3a 2.04, ddd (13.0, 7.8, 6.8) 30.5 Choi H-2
3b 1.78, ddd (13.0, 13.0, 9.0)
3a 2.28, m 36.1
4ax 2.08, m 19.5
4eq 1.47, m
5eq 1.56, m 24.5
5ax 1.49, m
6 3.84, m 70.05 Xyl H-1
7eq 2.27, brdd (14.0, 4.8) 29.2
7ax 1.57, brdd (14.0, 11.6)
7a 4.15, ddd (11.6, 6.2, 4.8) 54.11 Choi H-3a, H-4eq, H-7eq
Aeap 1a 3.21, m 36.6 Aeap NH, H-2a, H-2b
1b 3.17, m
2a 2.28, m 28.2 Aeap H-1, H-4
2b 2.26, m
3 136.2 Aeap H-1, H-2a, H-2b, H-4, H-7
4 5.61, brs 119.1 Aeap H-2a, H-2b, H-5
5 4.10, m 54.08
6 154.2
7 4.09, m 55.3 Aeap H-4
NH 7.74, t (5.8)
Xyl 1 4.81, d (3.4) 96.5 Xyl H-3, H-5ax
2 3.21, dd (9.4, 3.4) 71.94 Xyl H-3
3 3.40, dd (9.4, 8.8) 73.4 Xyl H-1, H-2, H-5ax, H-5eq568 Chemistry & Biology 14, 565–576, May 2007 ª2007 Elsevier Ltd All rights reserved
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Unit C/H No. dH (J in Hz) dC HMBC
4 3.28, m 70.03 Xyl H-3, H-5ax
5eq 3.39, m 62.1 Xyl H-1
5ax 3.34, dd (10.6, 10.6)aerA-aerI. The function of ten additional ORFs remained
obscure (Table 2 and Figure 3A). Nine of the Aer proteins
are encoded in the aerA-I cluster. Upstream of the aer re-
gion, a gene was transcribed in the opposite direction en-
coding a protein with 51% similarity to the cyanobacterial
circadian clock protein KaiA that was not considered to be
involved in aeruginoside production (ORF1) (Figure 3A).
Further upstream, a second ORF encoded a protein with
no significant similarity to characterized proteins and was
also not assigned to the biosynthesis (ORF2) (Figure 3A). A
third ORF encoded between the aerB and aerC genes did
not show any similarity to biosynthetic proteins and was
thus not expected to be involved in aeruginoside biosyn-
thesis (ORF3) (Figure 3A). Downstream of the aerA-I gene
cluster, seven additional genes were sequenced. An over-
view of the deduced functions of these (ORF4–ORF10) is
given in Table 2. One of these genes encodes a protein
with 46% similarity to a glycosyltransferase and was
designated aerI. This tailoring activity is needed for the
modification of the aeruginosin base structure and was
therefore attributed to aeruginoside biosynthesis. The se-
quence of the aer gene cluster and flanking regions has
been deposited in the EMBL database (accession number
AM071396). In the following section, the individual Aer
proteins are analyzed in detail. A schematic representa-
tion of the predicted aeruginoside biosynthesis pathway
is shown in Figure 3B.
In Silico Analysis of AerA-J Proteins
The first protein encoded by the aer gene cluster, AerA,
represents an unusual PKS-like module comprising a
NRPS A-domain, a ketoreductase (KR) domain, and an
acyl carrier protein (ACP) domain. Analysis of the sub-
strate binding pocket showed closest similarity to the A
domain of the microcystin biosynthesis protein McyG
that is known to activate diverse phenylpropanoid starter
units in vitro [29] (Table S1). It is therefore proposed that
AerA activates phenylpyruvate, which is reduced by theChemistry & Biology 14,ketoreductase domain to yield the Plac moiety of aerugi-
noside. The rare phenylpyruvate starter [30] is likely pro-
vided in sufficient amounts by the shikimate pathway.
Further downstream, the aerB gene encodes a NRPS
module comprising a C, A, PCP, and E domain. This gene
was initially inactivated resulting in the loss of aerugino-
side production. As mentioned above, the substrate acti-
vating binding pocket shows close similarity to leucine
activating domains (Table S1). The AerB module is thus
expected to incorporate D-leucine into the peptide struc-
ture. AerC contains signature sequences of ring-hydroxyl-
ating dioxygenases and a conserved Rieske [2Fe-2S]
domain (Table 2).
AerD, E, and F show 58%, 45%, and 55% amino acid
sequence similarity to BacA, BacB, and BacC of bacilysin
biosynthesis. These three enzymes are involved in the
biosynthesis of the anticapsin moiety [31] of bacilysin
(L-alanyl-(2,3-epoxycylohexan-4-one)L-alanine). An align-
ment of the sequences of the Bac enzymes from Bacillus
amyloliquefaciens and Bacillus subtilis [31] and of the
corresponding Ywf enzymes encoded in the completely
sequenced genome of Bacillus subtilis subsp. subtilis str.
168 [32] with AerD, AerE, and AerF, respectively, is pro-
vided as Supplemental Data (Figure S3). Feeding studies
and studies of knock out mutants of chorismate mutase
have revealed prephenate as precursor of the anticapsin
moiety [33]. A motif scan of AerD using protein family anal-
ysis software (http://www.sanger.ac.uk/Software/Pfam/
search.shtml) showed a conserved prephenate dehydra-
tase signature. Prephenate is a known intermediate of phe-
nylalanine and of tyrosine biosynthesis in many organisms.
We conclude that AerD is involved in the biosynthesis of
Choi in vivo. BacB and AerE, respectively, contain a con-
served cupin domain. Although the role of this domain is
not well understood, it is conserved among several dioxy-
genases [34]. BacB could perform the epoxidation step in
anticapsin synthesis. It is not clear, what function could be
fulfilled by the related enzyme AerE in Choi biosynthesis.Figure 2. Structures of Aeruginoside
126A (1) and 126B (2)
D-Plac, D-phenyl lactic acid; Choi, 2-carboxy-
6-hydroxyoctahydroindole; Aeap, 1-amino-2-
(N-amidino-D3-pyrrolinyl)ethyl; Agm, agmatin;
Xyl, xylose.565–576, May 2007 ª2007 Elsevier Ltd All rights reserved 569
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Protein
Amino
Acids
Deduced
Function
Sequence
Similarity
Identity/Similarity
(AA Length)
Accession
Number
AerA 1416 PKS (A KR ACP) BarE (Lyngbya majuscula) 44%/64% (587) AAN32979
AerB 1598 NRPS (C A T E) NosC (Nostoc sp. GSV224) 54%/71% (944) AAF17280
AerC 736 Oxygenase Putative diaminopimelate decarboxylase
(Burkholderia mallei 10229)
30%/49% (707) ZP00431845
AerD 202 Decarboxylase BacA (Bacillus amyloliquefaciens
AAM90573)
39%/58% (191) AAM90573
AerE 213 Unknown BacB (Bacillus subtilis) 26%/45% (208) AAM90569
AerF 264 Reductase BacC (Bacillus subtilis) 36%/55% (256) AA65204
AerG 1622 NRPS (C A T C T) McyB (Microcystis aeruginosa) 47%/64% (927) AAE09608
AerH 308 Dioxygenase Thymine dioxygenase (Rhodotorula glutinis) 30%/50% (517) AAU12179
AerI 418 Glycosyltransferase Spore coat protein SA (Bacillus subtilis) 26%/46% (336) P46915
ORF1 248 Circadian clock protein KaiA (Synechococcus elongatus) 31%/51% (227) 1R8JA
ORF2 126 Unknown no similarity
ORF3 288 Unknown no similarity
ORF4 229 Unknown no similarity
ORF5 170 Unknown Putative reverse transcriptase
(Nostoc sp. PCC7120))
70%/83% (157) BAB77479
ORF6 428 Unknown Retron-type reverse transcriptase
(Anabaena variabilis ATCC29413)
58%/74% (415) ABA24728
ORF7 386 Oxidoreductase Putative aldo/keto reductase
(Tricodesmium erythraeum IMS101)
70%/84% (383) ZP00328942
ORF8 339 Sulfotransferase Putative sulfotransferase
(Shewanella sp. PV-4)
22%/39% (228) EAP04083
ORF9 664 ABC-type transporter NcpC (Nostoc sp. ATCC 53789) 57%/75% (663) AAO23332
ORF10 257 Succinate dehydrogenase Succinate dehydrogenase
(Sulfolobus tokodaii)
33%/53% (238) BAB40685Finally, AerF and BacC, respectively, show close similarity
to dehydrogenases and reductases. On the basis of the
preceeding analysis, we propose that AerC, AerD, AerE,
and AerF provide the Choi moiety of aeruginoside. A bio-
chemical model for the biosynthetic route to Choi is
discussed below.
Downstream of the aerD-F region, the aerG gene en-
codes a NRPS module with the domain order C, A, PCP,
C, and PCP. The analysis of the substrate binding pocket
of the A domain revealed closest similarity to enzymes
activating proline or methylproline, although part of the
specificity conferring residues differ from typical proline-
activating domains. This suggests that a proline-like amino
acid rather than proline itself is activated (Table S1). It is
interesting to note that spumigin, a peptide isolated from a
Nodularia strain, is similar to aeruginosin but contains a
methylproline moiety instead of Choi [35]. In Planktothrix,
however, it is expected that AerG directly activates and in-
corporates the Choi moiety (see also feeding studies be-
low). It is not clear to which extent the second C domain
and, in particular, the second PCP domain of AerG are in-
volved in aeruginoside biosynthesis. Amide bond forma-570 Chemistry & Biology 14, 565–576, May 2007 ª2007 Elsevietion principally functions with a free-standing C domain,
such as for the VibH enzyme in vibrobactin biosynthesis
[36]. The second C and PCP domains of AerG in Plankto-
thrix may be remnants of a complete NRPS module. It is of
note that aeruginosin-type metabolites are known from
Microcystis aeruginosa in which the C-terminal carboxyl
group of arginine is reduced to the aldehyde and/or alco-
hol oxidation state [4, 6]. Production of metabolites of the
latter type requires a functional, complete module and
a reductase in order to effect release of the peptide from
the enzyme. The structure of AerG from the Planktothrix
aer cluster suggests that in this organism the synthetase
may be able to add the agmatine/Aeap moiety to the
growing peptide chain with just a C domain. Since agma-
tine and Aeap lack the carboxyl that would otherwise
tether the growing peptide to the synthetase, a thioester-
ase or domain for a reductive release is not required in
the Planktothrix enzyme. We therefore postulate that the
release of the peptide from the enzyme complex is trig-
gered by amide bond formation between the PCP-bound
carboxyl group of Choi and the primary amine of agmatine
or of Aeap.r Ltd All rights reserved
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Aeruginoside Biosynthesis in CyanobacteriaFigure 3. Biosynthetic Pathway of Aeruginosides 126A and 126B
(A) Schematic representation of the aeruginoside biosynthesis gene cluster of Planktothrix agardhii CYA126/8. Genes encoding NRPS or NRPS/PKS
hybrid components are indicated in light and dark gray, respectively. Genes presumably involved in Choi biosynthesis are checkered, and tailoring
genes are highlighted with stripes. Genes that were not associated with aeruginoside biosynthesis are shown in white.
(B) Model for the formation of aeruginoside A and B and predicted domains of AerA-AerI. Each circle represents a NRPS domain or tailoring function.
A, adenylation domain; KR, ketoreductase domain; ACP, acyl carrier protein; C, condensation domain; PCP, peptidyl carrier protein; E, epimerization
domain.The AerH protein shows similarity to oxygenases includ-
ing isopenicillin N synthase and related enzymes from var-
ious bacteria. This enzyme may have a function in Aeap
biosynthesis from arginine or agmatine. However, since
the origin of carbon atoms in the Aeap residue is not pres-
ently known, this assignment is speculative at this time.
The putative tailoring enzyme AerI shows similarity to gly-
cosyltransferases. A glycosyltransferase is needed for the
transfer of the xylose moiety to the hydroxyl group of Choi.
Although the specificity of the glycosyltransferase cannot
be deduced from the sequence, the close proximity of the
gene to aeruginosin biosynthesis genes suggests a role in
aeruginoside biosynthesis.
Taken together, the in silico analysis of the enzymes
encoded by the aer gene cluster suggests roles for the
enzymes in aeruginoside biosynthesis. The majority of
enzymatic reactions proposed are in agreement with the
synthesis of the tetrapeptide (Figure 3B). However, several
of the enzymatic steps remain obscure at this point, par-
ticularly as far as Aeap biosynthesis is concerned. In order
to obtain further insights into some of the reactions in-
volved in Choi biosynthesis, we constructed additional
mutants and initiated feeding studies.
Mutagenesis of Putative Choi Biosynthesis Genes
and Feeding Studies
In order to confirm the proposed involvement of AerD,
AerE, and AerF in the synthesis of the Choi moiety, two
knockout constructs were designed. For both constructs,Chemistry & Biology 14,a chloramphenicol resistance cassette was inserted into
the aerD–aerF region. The first construct was bearing a
deletion in the aerE–aerF region, whereas in the second
experiment the antibiotic cassette was inserted into the
aerD gene (Figure 4A). Both constructs were introduced
into Planktothrix by electroporation. Mutants obtained
after 3 months were analyzed by PCR and revealed the
successful homologous recombination of the construct
DNA (Figure 4B). Extracts of broths from both mutants,
designated DaerEF and DaerD, were compared to the
wild-type by LC-ESI-MS (Figures 4C, 4D, and 4F). While
the wild-type spectrum revealed the characteristic aerugi-
noside peak at 10 min (m/z 714.80–715.80), no aerugino-
side could be detected in the mutants (Figures 4C, 4D, and
4F). Following this observation, both mutants were fed with
external L-Choi hydrochloride [37] and reanalyzed by LC-
ESI-MS. Mass spectra of cell mass of the mutant after
Choi feeding clearly revealed the production of aerugino-
side (Figures 4E and 4G). These results confirmed the
proposed involvement of the aerD–aerF genes in Choi
biosynthesis. Moreover, the results indicate that Choi is
directly activated at the AerG enzyme rather than
being synthesized as an enzyme-bound intermediate.
This conclusion is further supported by the fact that free
Choi could be detected in the wild-type strain Planktothrix
CYA126/8 and in the DaerB mutant strain (data not
shown).
Although AerD–AerF look strikingly similar to the BacA–
BacC enzymes of Bacillus, the Choi moiety and the565–576, May 2007 ª2007 Elsevier Ltd All rights reserved 571
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Aeruginoside Biosynthesis in CyanobacteriaFigure 4. Analysis of Putative Choi Biosynthesis Genes
(A and B) Inactivation of putative Choi biosynthesis genes by homologous recombination. (A) Schematic representation of DaerEF and DaerD knock-
out plasmids for the insertional mutagenesis of P. agardhii CYA126/8. Chloramphenicol resistance gene cassettes (Cmr) are highlighted in black. (B)
PCR amplification with the DNA from wild-type (lanes 1 and 4), DaerEF andDaerD mutants (lanes 2 and 5), and DaerEF and DaerD plasmid constructs
(lanes 3 and 6) with primers amplifying the aerD–aerF (lanes 1–3) and the aerD (lanes 4–6) regions, respectively.
(C–G) LC-ESI MS (positive SIM, range m/z 714.80–715.80) of extracts from (C) P. agardhii CYA126/8 WT, (D) P. agardhii CYA126/8 DAerEF, (E)
P. agardhii CYA126/8 DAerEF + Choi, (F) P. agardhii CYA126/8 DAerD, (G) P. agardhii CYA126/8 DAerD + Choi. 1; aeruginoside 126A.anticapsin moiety exhibit only limited structural similarity.
An adaptation of the enzymatic reactions of the bacilysin
pathway to Choi biosynthesis is not straightforward as
the sequence of reactions in Bacillus is not well under-
stood. Both pathways have in common that direct feeding
with tyrosine itself did not result in any evidence for its in-
corporation into either Choi (this work and data not shown)
or anticapsin [38]. This suggests that a tyrosine precursor
is the obligatory intermediate in these two pathways. In
the case of anticapsin biosynthesis it has been suggested
that prephenate, an intermediate of phenylalanine biosyn-
thesis, might fulfill this function [33]. This view is supported
by the observation that there is strong sequence similarity572 Chemistry & Biology 14, 565–576, May 2007 ª2007 Elseviebetween BacA and AerD and prephenate decarboxylases.
However, although Choi bears an amino group, an en-
zyme potentially transferring an amino group is not en-
coded within the aeruginoside gene cluster. Therefore,
we propose that the amino group of Choi is provided by
arogenate (pretyrosine), a known intermediate of tyrosine
biosynthesis in cyanobacteria [39]. Arogenate could po-
tentially also serve as precursor for anticapsin biosynthe-
sis (Figure 5A). On the basis of these assumptions, the
hypothetical Choi biosynthetic pathway is proposed as
follows (Figure 5B): arogenate is oxidized by AerC to pro-
duce 3, which is cyclized via Michael addition. This step
must be enzyme catalyzed in order for the correctFigure 5. Proposed Biosynthetic Path-
ways of the Anticapsin Moiety of Bacily-
sin and the Choi Moiety of Aeruginosin
(A) Biosynthetic model for the formation of anti-
capsin starting from arogenate.
(B) Biosynthetic model for the formation of Choi
starting from arogenate.r Ltd All rights reserved
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Aeruginoside Biosynthesis in Cyanobacteriadiastereomer of Choi to be produced: addition of the a-
amino group to the pro-R carbon of the dienone results
in the 2S, 3aR, 7aR diastereomer of 4, whereas addition
to the pro-S carbon results in the 2S, 3aS, 7aS diastereo-
mer of 4. The resulting vinylogous b-keto acid 4 is decar-
boxylated by AerD to yield the bicyclic amino acid 5, which
may be reduced by AerF (Figure 5B). This model is chem-
ically reasonable but will require additional refinement
through future enzymological studies after the complete
heterologous expression of the AerD–AerF region or
through further mutagenesis studies.
SIGNIFICANCE
Many cyanobacterial metabolites are infamous as
health-threatening toxins that occur in bacterial
blooms. However, various natural products from these
organisms show important biological activities, such
as the aeruginosins, which specifically inhibit serine
proteases and are regarded as promising drug can-
didates. Aeruginosins are also interesting from a
structural point of view, as they represent unusual
cyanobacterial peptides that contain a unique 2-car-
boxy-6-hydroxyoctahydroindole (Choi) moiety. We
have identified a putative aeruginoside biosynthesis
genes in the genome of the freshwater cyanobacte-
rium Planktothrix agardhii CYA126 and succeeded in
unequivocally proving its identity by directed muta-
genesis of a NRPS core component encoded by the
cluster. Comparison of the metabolic profiles led to
the discovery and structural elucidation of two previ-
ously unreported glycopeptides, which were named
aeruginosides 126A and 126B. The aeruginoside bio-
synthesis pathway from Planktothrix CYA126/8 pro-
vides a novel example for a complexmolecular assem-
bly line composed of NRPS featuring an unusual
loading module as well as an extender module for the
uniqueChoimoietyandaputativeglycosyltransferase.
Heterologous expression of aeruginoside pathway
genes for sustainable production or engineering of
potential aeruginoside-derived drugs would be to be
a promising alternative to chemical de novo synthesis
in the future.
EXPERIMENTAL PROCEDURES
Bacterial Strains and Culturing
The axenic strain P. agardhii CYA126/8 was provided by Prof. K. Sivo-
nen (University of Helsinki, Helsinki, Finland). Wild-type and mutant
strains were cultured in Z8 medium as described previously [16]. Cul-
tures were maintained under continuous white light (30 mEm2 s1)
on a shaker with 40 or 80 rpm at 23C. DNA manipulations were
performed in Escherichia coli XL1 Blue in LB medium. E. coli XL1
Blue MRF0 Kan strain was used for the excision of lambda phagemids,
according to the suggestions of the manufacturer (Stratagene, La
Jolla, CA).
Construction and Screening of the Phagemid Library
The isolation of chromosomal DNA from P. agardhii CYA126/8 and the
construction of a lambda ZAP library were previously reported [16].Chemistry & Biology 14,Screening of the library was performed by hybridization. Clone gaps
were connected by PCR or inverse PCR, respectively, by using Pfu
polymerase (Stratagene, La Jolla, CA).
Analysis of Aeruginosides
Cells of WT strain CYA126/8 and the mutant cultures grown in BG11
medium22 at 20C (15 mE m2 s1) were harvested on preweighed
glass fiber filters (GF/C). The cell mass was freeze dried, and the filters
were reweighed for the determination of the dry weight (6 mg of DW
each for WT and the mutant). Filters were extracted in aqueous
MeOH (50/50, v/v) on a shaker for 60 min. The extract was centrifuged,
and the supernatant cleaned up by solid phase extraction (SPE) with
Sep-Pak tC18 cartridges (Waters, Vienna, Austria). The tC18 car-
tridges were conditioned by using MeOH followed by equilibration
with 25% aq. MeOH (v/v). Samples were applied in 25% aq. MeOH,
the cartridge was washed with five bed volumes of the same solvent,
and aeruginosins were eluted with 80% MeOH (v/v). The cleaned ex-
tract was resuspended in 100 ml of 50% MeOH, and 100 ml were in-
jected with HPLC-DAD (HP1100) and separated on a LiChrosper 100,
ODS, 5 mm, LiChroCART 250-4 cartridge system (Merck, Darmstadt,
Germany) by using a linear gradient of aq. acetonitrile (with 0.05%
v/v trifluoracetic acid, TFA) starting with 20% acetonitrile (v/v) and
increasing up to 50% acetonitrile within 45 min with a flow of 1 ml
min1. Peptides were detected at 210 nm.
Isolation of Aeruginosides
Fourty-five liters of CYA126/8 were grown as described above, har-
vested by filtration through a sieve with a mesh size of 3 mm by using
low pressure vacuum, and the cell mass was freeze dried. Cells
were extracted with 50% MeOH (see above), and the extracts injected
after SPE purification as described. HPLC purification was performed
by using a linear gradient of aqueous acetonitrile (0.05% v/v TFA) start-
ing with 20% acetonitrile (v/v) and increasing up to 30% acetonitrile
within 15 min with a flow of 1 ml min1. The compounds were colorless
oils and HPLC analysis of the purified compounds did not show UV
absorbing contaminants.
Aeruginoside 126A (1)
Amorphous colorless solid; [a]25D 137 (c 0.0025 H2O);
1H NMR and 13C
NMR, see Table 1; HRESITOFMS (positive ion mode) [M+H]+ 715.4056
(715.4031 calculated).
Aeruginoside 126B (2)
Amorphous colorless solid; [a]25D 122 (c 0.0039, H2O);
1H NMR (500
MHz), DMSO-d6 d Plac: 7.25 (2H, t, J = 7.4 Hz, H-6/8), 7.21 (2H, d, J =
7.4 Hz, H-7), 7.17 (1H, m, H-5/9), 4.11 (1H, dd, J= 8.8, 3.7 Hz, H-2), 2.96
(1H, dd, J = 13.4, 3.7 Hz, H-3a), 2.64 (1H, dd, J = 13.4, 8.8 Hz, H-3b);
Leu: 7.77 (1H, d, J = 7.8 Hz, NH), 4.53 (1H, m, H-2), 1.48 (1H, m, H-4),
1.46 (1H, m, H-3a), 1.34 (1H, m, H-3b), 0.87 (3H, d, J = 6.4 Hz, H-5),
0.84 (3H, d, J = 6.8 Hz, H-50); Choi: 4.18 (1H, dd, J = 8.9, 8.5 Hz, H-2),
4.16 (1H, m, H-7a), 3.85 (1H, m, H-6), 2.30 (1H, m, H-3a), 2.29 (1H, m,
H-7eq), 2.09 (1H, m, H-4ax), 2.03 (1H, m, H-3a), 1.83 (1H, m, H-3b),
1.61 (1H, m, H-7ax), 1.57 (1H, brd, J = 12.7 Hz, H-5eq), 1.50 (1H, m,
H-5ax), 1.48 (1H, m, H-4eq); Agm: 7.74 (1H, t, J = 5.6 Hz, NH-1), 7.44
(1H, t, J = 5.6 Hz, NH-4), 3.08 (2H, m, H-4), 3.05 (2H, m, H-1), 1.44
(2H, m, H-2), 1.43 (2H, m, H-3); Xyl: 4.82 (1H, d, J = 3.6 Hz, H-1), 3.40
(1H, dd, J = 9.0, 9.0 Hz, H-3), 3.39 (1H, m, H-5eq), 3.34 (1H, dd, J =
11.0, 11.0 Hz, H-5ax), 3.28 (1H, m, H-4), 3.22 (1H, dd, J = 9.0, 3.6 Hz,
H-2); 13C NMR (125 MHz, DMSO-d6) d Plac: 173.2 ((1) C-1), 138.5 ((1)
C-4), 129.4 ((2) C-5/9), 128.0 ((2) C-6/8), 126.0 ((2) C-7), 72.06 ((2)
C-2), 40.46 ((3) C-3); Leu: 169.8 ((1) C-1), 48.5 ((2) C-2), 41.3 ((3) C-3),
24.2 ((2) C-4), 23.4 ((4) C-50), 21.9 ((4) C-5); Choi: 171.6 ((1) C-1), 70.12
((2) C-6), 59.9 ((2) C-2), 54.1 ((2) C-7a), 36.1 ((2) C-3a), 30.5 ((3) C-3),
29.3 ((3) C-7), 24.5 ((3) C-5), 19.5 ((3) C-4); Agm: 156.7 ((1) C-5), 40.56
((3) C-4), 37.9 ((3) C-1), 26.2 ((3) C-2), 25.8 ((3) C-3); Xyl: 96.6 ((2) C-1),
73.5 ((2) C-3), 72.0 ((2) C-2), 70.07 ((2) C-4), 62.2 ((3) C-5); HRESITOFMS
(positive ion mode) [M+H]+ 691.4051 (691.4031 calculated, D =
2.0 mmu).565–576, May 2007 ª2007 Elsevier Ltd All rights reserved 573
Chemistry & Biology
Aeruginoside Biosynthesis in CyanobacteriaAnalysis of Stereochemistry of 1
Aeruginoside A (0.5 mg) was heated in 0.5 ml 6 N HCl at 110C for
16 hr. After cooling to rt, the solution was extracted with EtOAc (3 3
0.5 ml), and the organic layer was removed under a stream of nitrogen.
The residue was dissolved in MeOH, and a portion was injected onto
a Chiralpak MA(+) column equilibrated in 2 mM aqu. CuSO4/ CH3CN
(85:15) and eluted at 0.8 ml min1. D-Plac eluted at 41 min (retention
time L-Plac: 59 min).
The aqueous layer from the hydrolysis was evaporated under a
stream of nitrogen, and a portion of the residue was injected onto a
Chirex D column equilibrated in 2 mM aqu. CuSO4/CH3CN (95:5, v/v)
and eluted at 0.8 ml min1. D-Leu eluted at 61.7 min (retention time
L-Leu: 51.4 min).
Protease Inhibition Assays
Serine protease inhibitory activities were analyzed as described previ-
ously [40] by using porcine pancreas trypsin (Sigma; St. Louis, USA),
bovine plasma thrombin (Sigma; St Louis, USA), and human plasma
plasmin (Sigma; St. Louis, USA). Aeruginosin 98A from M. aeruginosa
NIES98 was used as a positive control.
Construction of the Gene Disruption Plasmids
for aerB, aerD, and aerEF
The phagemid pBK-CMV-DaerB was digested with XcmI (E1 site in ep-
imerization domain). After blunting of the phagemide ends by Klenow
treatment, the 1.4 kb BsaAI fragment from pACYC184 containing the
chloramphenicol resistance cassette was inserted. Positive clones
containing the antibiotic resistance cassette were identified by restric-
tion analysis. The phagemid pBK-CMV-DaerD was digested with
EcoRI and XhoI to remove a HindIII-recognition site. Subsequently,
sticky ends of the plasmid were blunted as described above. The re-
sulting plasmid was purified (Qiaquick, QIAGEN, Hilden, Germany)
and self-ligated. The derived plasmid was digested with HindIII and
then blunted as described above. The 1.4 kb BsaAI fragment from
pACYC184 containing the chloramphenicol resistance cassette was
cloned into the blunted plasmid. Positive clones and the orientation
of the antibiotic cassette were identified by restriction analysis.
A 6115 bp gene fragment containing aerEF was amplified by PCR
with the primers Pa36_61Arv3 (50-AAG CAG GAA GCT TCA CTT GG-
30 ) and Dhg1641rv5 (50-CCT GCA ATC ACA AAC AAT TAC T-30 ) with
Pfu polymerase (Stratagene, La Jolla, CA). The resulting PCR product
was treated with Taq polymerase (72C for 30 min) and purified with
a gel purification kit (Qiaquick, QIAGEN, Hilden, Germany). The purified
DNA was cloned into the pDrive vector (QIAGEN, Hilden, Germany). A
1,178 bp fragment covering the region between 50 end of aerE to the
mid of aerF was deleted with PacI and blunted by Klenow treatment.
The 1.4 kb BsaAI fragment from pACYC184 containing the chloram-
phenicol resistance cassette was cloned into the blunted plasmid
generating the gene disruption plasmid pDrive-DaerEF. The antibiotic
resistance clones were identified by restriction analysis.
Planktothrix Mutagenesis
The three constructs (15 to 20 mg of plasmid DNA) were linearized in the
multicloning site of the vectors using BamHI. The restricted DNA was
column purified (Qiaquick, QIAGEN, Hilden, Germany), denaturated at
95C for 10 min, and then immediately put onto an ice bath. Fifty mil-
liliters of cultured algal cells were centrifuged at 6,000 rpm and washed
three times with 1 mM HEPES buffer and centrifuged. Cells were
resuspended in 1 mM HEPES and subjected to electroporation with
10 mg of the single-strand plasmid DNA (1.0 kV, 25 mF, 200 U).
Transformed cyanobacterial cells were inoculated in 100 ml of Z8
medium and cultivated as described above. After three days, 50 mg
of chloramphenicol was added to culture medium. After 4 to 6 weeks,
a fresh Z8 medium containing 0.5 mg ml1 chloramphenicol was added
to the cultures. Transformants were purified by increasing stepwise the
chloramphenicol concentration up to 5 mg ml1 (8 to 12 weeks).574 Chemistry & Biology 14, 565–576, May 2007 ª2007 ElsevieDNA Sequencing and Sequence Analysis
Sequencing of phagemids was performed by primer walking with the
Big Dye terminator cycle sequencing kit (ABI, Foster City, USA). Anal-
yses of DNA sequences and deduced amino acid sequences were
performed with the NCBI (National Institute for Biotechnology Informa-
tion, Bethesda, MD) BLAST server (http://www.ncbi.nlm.nih.gov/) and
the ExPASy proteomics server (http://www.expasy.ch/) of the Swiss
Institute of Bioinformatics (Geneve, Switzerland).
HPLC-ESIMS Analysis of Aeruginosides and Feeding
Experiments
One 200 ml aliquot of wild-type and two 200 ml aliquots of the DaerD
and DaerEF mutant cells were cultivated as described above. One al-
iquot of theDaerD and DaerEF mutant, respectively, was fed with 2 mg
L-ChoiHCl in the early logarithmic phase. All cultures were grown until
they reached late logarithmic phase (OD750: 1.0), centrifuged, and
freeze dried.
Freeze-dried algal cells were extracted twice with 80% MeOH
(10 ml/100 ml cultured cells) and once with MeOH (10 ml/100 ml cul-
tured cells). Combined 80% MeOH and MeOH extracts were concen-
trated to an aqueous suspension, which was then washed with dieth-
ylether. The aqueous layer was extracted with n-BuOH. The n-BuOH
layer was evaporated under reduced pressure and dissolved in 50%
MeOH (0.5 ml/100 ml cultured cells). Sample solutions were analyzed
by LC-ESIMS (Finnigan TSQ Quantum ULTRA ThermoFinnigan
Surveyor HPLC system, Thermo Electron Corporation, Waltham,
MA, USA) by using reversed-phase HPLC (PRONTOSIL 120-5-C18
ace-EPS (4.0 3 250 mm, Bischoff Chromatography, Leonberg, Ger-
many) with a linear gradient of 10% to 80% acetonitrile containing
0.1% AcOH in 35 min at a flow rate of 1.0 ml min1.
Supplemental Data
Supplemental Data include a comparison of the putative specificity-
conferring codes of adenylation domains involved in aeruginoside bio-
synthesis, NMR spectra of aeruginosides, and 1D NOE and ROESY
correlations for the Choi residue and are available at http://www.
chembiol.com/cgi/content/full/14/5/565/DC1/.
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